Quantitative Inductively Coupled Plasma-Mass Spectrometry
New York DOH Approval Status
This test is New York DOH approved.
- Patient Preparation
- Diet, medication, and nutritional supplements may introduce interfering substances. Patients should be encouraged to discontinue nutritional supplements, vitamins, minerals, and non-essential over-the-counter medications (upon the advice of their physician). High concentrations of iodine may interfere with elemental testing. Abstinence from iodine-containing medications or contrast agents for at least 1 month prior to collecting specimens for elemental testing is recommended.
- 24-hour or random urine collection. Specimen must be collected in a plastic container. ARUP studies indicate that refrigeration of urine alone, during and after collection, preserves specimens adequately, if tested within 14 days of collection.
- Specimen Preparation
- Transfer an 8 mL aliquot from a well-mixed collection to ARUP Trace Element-Free Transport Tubes (ARUP supply #43116). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. (Min: 1 mL) Record total volume and collection time interval on transport tube and on test request form.
- Storage/Transport Temperature
- Refrigerated. Also acceptable: Room temperature or frozen.
- Unacceptable Conditions
- Urine collected within 48 hours after administration of a gadolinium (Gd) containing contrast media (may occur with MRI studies). Acid preserved urine.
- Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 year
|Test Number||Components||Reference Interval|
|Chromium, Urine-per volume||0.0-5.0 µg/L|
|Chromium, Urine-per 24h||0.0-6.0 µg/d|
|Chromium, urine-ratio to CRT||No reference interval (µg/g crt)|
|0020473||Creatinine, 24-Hour Urine|
Chromium urine levels can be used to monitor short term exposure. The form of chromium greatly influences distribution. Trivalent chromium resides in the plasma and is usually not of clinical importance. Hexavalent chromium is considered highly toxic. Symptoms associated with chromium toxicity vary based upon route of exposure and dose and may include dermatitis, impairment of pulmonary function, gastroenteritis, hepatic necrosis, bleeding, and acute tubular necrosis.
|Component Test Code*||Component Chart Name|
|0020207||Creatinine, Urine - per volume|
|0020208||Creatinine, Urine - per 24h|
|0025101||Chromium, Urine - per 24h|
|0025102||Chromium, Urine - ratio to CRT|
|0099463||Chromium, Urine - per volume|